Infant Respiratory Syncytial Virus Bronchiolitis and Subsequent Risk of Pneumonia, Otitis Media, and Antibiotic Utilization | Zendy

Andrew Abreo | Zendy; Pingsheng Wu | Zendy; Brittney M. Donovan | Zendy; Tan Ding | Zendy; Tebeb Gebretsadik | Zendy; Xiang Huang | Zendy; Cosby A. Stone | Zendy; Kedir N. Turi | Zendy; Tina V. Hartert | Zendy

Open Access

Infant Respiratory Syncytial Virus Bronchiolitis and Subsequent Risk of Pneumonia, Otitis Media, and Antibiotic Utilization

Author(s) -

Andrew Abreo,

Pingsheng Wu,

Brittney M. Donovan,

Tan Ding,

Tebeb Gebretsadik,

Xiang Huang,

Cosby A. Stone,

Kedir N. Turi,

Tina V. Hartert

Publication year - 2019

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciz1033

Subject(s) - medicine , bronchiolitis , pneumonia , otitis , antibiotics , pneumovirus , respiratory system , respiratory disease , intensive care medicine , acute otitis media , virus , virology , paramyxoviridae , viral disease , lung , microbiology and biotechnology , surgery , biology

Infant respiratory syncytial virus (RSV) bronchiolitis in the first 6 months of life was associated with increased odds of pneumonia, otitis media, and antibiotic prescription fills in the second 6 months of life. These data suggest a potential value of future RSV vaccination programs on subsequent respiratory health.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research